Efficacy of lamivudine therapy for decompensated liver cirrhosis due to hepatitis B virus with or without hepatocellular carcinoma

Oncology Reports

Volumn 13, Issue 6, 2005, Pages 1159-1163

  Hiraoka, Atsushi ^a   Michitaka, Kojiro ^a   Kumagi, Teru ^a   Kurose, Kiyotaka ^a   Uehara, Takahide ^a   Hirooka, Masashi ^a   Yamashita, Yoshimasa ^b   Kubo, Yoshikazu ^c   Miyaoka, Hiroaki ^d   Iuchi, Hidehito ^e   Okada, Shinichi ^e   Ohmoto, Masaki ^f   Yamamoto, Kazuhisa ^g   Horiike, Norio ^a   Onji, Morikazu ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b EHIME PREFECTURAL CENTRAL HOSPITAL   (Japan)

^c National Hospital Organization Ehime Medical Center   (Japan)

^d Saiseikai Matsuyama Hospital   (Japan)

^e Saiseikai Saijo Hospital   (Japan)

^f Saiseikai Imabari Hospital   (Japan)

^g Matsuyama Shimin Hospital   (Japan)

Author keywords

Hepatic decompensation; Hepatitis B virus; Hepatocellular carcinoma; Lamivudine; Liver cirrhosis

Indexed keywords

LAMIVUDINE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOLOGY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TUMOR; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LAMIVUDINE; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE INHIBITORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 24744460110     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.13.6.1159     Document Type: Article

References (22)

1. Gane EJ, Portmann BC, Naoumov NV, et al: Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 334: 815-820, 1996. (Pubitemid 26099603)
2. Sawyer RG, McGory RW, Gaffey MJ, et al: Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunization. Ann. Surg 227: 841-850, 1998. (Pubitemid 29119531)
3. Mazzaferro V, Regalia E, Doci R, et al: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334: 693-699, 1996. (Pubitemid 26079803)
4. Tan KC, Rela M, Ryder SD, et al: Experience of orthotopic liver transplantation and hepatic resection for hepatocellular carcinoma of less than 8 cm in patients with cirrhosis. Br J Surg 82: 253-256, 1995.
5. Dienstag JL, Perillo RP, Schiff ER, Bartholomew M, Vicary C and Rubin M: A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 333: 1659-1661,1995.
6. Villeneuve JP, Condreary LD, Willems B, et al: Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B. Hepatology 31: 207-210, 2000. (Pubitemid 30033708)
7. Kapoor D, Guptan RC, Wakil SM, et al: Beneficial effects of lamivudine in hepatitis B virus-related decompensated cirrhosis. J Hepatol 33: 308-312, 2000. (Pubitemid 30485235)
8. Yao FY, Terrault NA, Freise C, Maslow L and Bass NM: Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort. Hepatology 34: 411-416, 2001. (Pubitemid 32702355)
9. Nakanishi S, Michitaka K, Miyake T, et al: Decompensated hepatitis B virus-related cirrhosis successfully treated with lamivudine allowing surgery for hepatocellular carcinoma. Intern Med 42: 416-420, 2003. (Pubitemid 36701565)
10. Liver Cancer Study Group of Japan: The general rules for the clinical and pathological study of primary liver cancer (in Japanese). 4th edition. Kanehara, Tokyo, p19, 2000.
11. Lin DY, Sheen IS, Chiu CT, Lin SM, Kuo YC and Liaw YF: Ultrasonographic changes of early liver cirrhosis in chronic hepatitis B: a longitudinal study. J Clin Ultrasound 21: 303-308, 1993.
12. Arii S, Yamamoto Y, Futagawa S, et al: Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 32: 1224-1229, 2000.
13. Okuda K, Ohtsuki T, Obata H, et al: Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Cancer 56: 918-928, 1985. (Pubitemid 15228292)
14. Llove JM, Bru C and Bruix J: Prognosis of Hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19: 329-337, 1999. (Pubitemid 29488775)
15. The Cancer of the Liver Italian Program (CLIP) Investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 28: 751-755, 1998.
16. Kudo M, Chung H and Osaki Y: Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol 38: 207-215, 2003. (Pubitemid 36527122)
17. Seki T, Nonaka T, Kubota Y, Mizuno T and Sameshima Y: Ultrasonically guided percutaneous ethanol injection therapy for hepatocellular carcinoma. Am J Gastroenterol 84: 1400-1407, 1989. (Pubitemid 19282064)
18. Rossi S, Buscarni E, Garbagnati F, et al: Percutaneus treatment of small hepatic tumors by an expandable RF needle electrode. Am. J. Roentgenol 170: 1015-1022, 1998. (Pubitemid 28172891)
19. Llovet JM, Real ML, Montana X, et al: Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 359: 1734-1739, 2002. (Pubitemid 34607087)
20. Imamura H, Seyama Y, Kokudo N, et al: One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 38: 1198-1206, 2003. (Pubitemid 37392393)
21. Perrillo R, Schiff E, Yoshida E, et al. Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants. Hepatology 32: 129-134, 2000. (Pubitemid 30432377)
22. Liaw YF: Management of YMDD mutation during lamivudine therapy in patients with chronic hepatitis B. J Gastroenterol Hepatol 17: 333-337, 2002.